Conmed (CNMD) Debt Ratio (2010 - 2026)
Conmed posted quarterly Debt Ratio of 0.37 for Q1 2026, down 4.23% year-on-year from 0.39 in Q1 2025, and up 3.59% on a QoQ basis from 0.36 in Q4 2025.
Conmed (CNMD) has 17 years of Debt Ratio data on file, last reported at 0.37 in Q1 2026.
- For the quarter ending Q1 2026, Debt Ratio fell 4.23% year-over-year to 0.37; the trailing twelve-month figure through Mar 2026 stood at 0.37 (down 4.23% YoY), and the FY2025 full-year result was 0.36, down 8.59% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.37, up from 0.36 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.47 in Q2 2022 and bottomed at 0.36 in Q4 2025.
- The 5-year median for Debt Ratio is 0.42 (2024), against an average of 0.42.
- The widest annual swing landed in 2022, when Debt Ratio grew 18.42%; it then retreated 10.38% in 2025.
- A 5-year view of Debt Ratio shows it stood at 0.46 in 2022, then slipped by 7.77% to 0.42 in 2023, then decreased by 7.24% to 0.39 in 2024, then retreated by 8.59% to 0.36 in 2025, then rose by 3.59% to 0.37 in 2026.
- The last three Debt Ratio figures came in at 0.37 (Q1 2026), 0.36 (Q4 2025), and 0.37 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.31 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.04 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.25 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.27 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.18 |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn | 0.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.37 |
| Dec 31, 2025 | 0.36 |
| Sep 30, 2025 | 0.37 |
| Jun 30, 2025 | 0.38 |
| Mar 31, 2025 | 0.39 |
| Dec 31, 2024 | 0.39 |
| Sep 30, 2024 | 0.41 |
| Jun 30, 2024 | 0.42 |
| Mar 31, 2024 | 0.43 |
| Dec 31, 2023 | 0.42 |
| Sep 30, 2023 | 0.44 |
| Jun 30, 2023 | 0.45 |
| Mar 31, 2023 | 0.46 |
| Dec 31, 2022 | 0.46 |
| Sep 30, 2022 | 0.45 |
| Jun 30, 2022 | 0.47 |
| Mar 31, 2022 | 0.40 |
| Dec 31, 2021 | 0.39 |
| Sep 30, 2021 | 0.41 |
| Jun 30, 2021 | 0.41 |
| Mar 31, 2021 | 0.43 |
| Dec 31, 2020 | 0.43 |
| Sep 30, 2020 | 0.45 |
| Jun 30, 2020 | 0.47 |
| Mar 31, 2020 | 0.45 |
| Dec 31, 2019 | 0.43 |
| Sep 30, 2019 | 0.45 |
| Jun 30, 2019 | 0.46 |
| Mar 31, 2019 | 0.46 |
| Dec 31, 2018 | 0.33 |
| Sep 30, 2018 | 0.34 |
| Jun 30, 2018 | 0.33 |
| Mar 31, 2018 | 0.34 |
| Dec 31, 2017 | 0.36 |
| Sep 30, 2017 | 0.37 |
| Jun 30, 2017 | 0.37 |
| Mar 31, 2017 | 0.38 |
| Dec 31, 2016 | 0.38 |
| Sep 30, 2016 | 0.38 |
| Jun 30, 2016 | 0.39 |
| Mar 31, 2016 | 0.39 |
| Dec 31, 2015 | 0.25 |
| Sep 30, 2015 | 0.24 |
| Jun 30, 2015 | 0.24 |
| Mar 31, 2015 | 0.24 |
| Dec 31, 2014 | 0.22 |
| Sep 30, 2014 | 0.22 |
| Jun 30, 2014 | 0.22 |
| Mar 31, 2014 | 0.22 |
| Dec 31, 2013 | 0.20 |
| Sep 30, 2013 | 0.21 |
| Jun 30, 2013 | 0.22 |
| Mar 31, 2013 | 0.21 |
| Dec 31, 2012 | 0.15 |
| Sep 30, 2012 | 0.16 |
| Jun 30, 2012 | 0.16 |
| Mar 31, 2012 | 0.18 |
| Dec 31, 2011 | 0.15 |
| Sep 30, 2011 | 0.18 |
| Jun 30, 2011 | 0.17 |
| Dec 31, 2010 | 0.20 |